- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/10 - AntiepilepticsAnticonvulsants for petit-mal
Patent holdings for IPC class A61P 25/10
Total number of patents in this class: 43
10-year publication summary
|
0
|
3
|
5
|
1
|
2
|
5
|
2
|
2
|
0
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Jazz Pharmaceuticals Research UK Limited | 256 |
5 |
| GW Research Limited | 147 |
3 |
| Sumitomo Pharma Co., Ltd. | 556 |
3 |
| Pfizer Inc. | 3404 |
2 |
| Centre National de La Recherche Scientifique | 11055 |
2 |
| GW Pharma Limited | 45 |
2 |
| Umecrine AB | 6 |
2 |
| The University of North Carolina at Chapel Hill | 2111 |
2 |
| F. Hoffmann-La Roche AG | 7815 |
1 |
| Hoffmann-La Roche Inc. | 3815 |
1 |
| The Regents of the University of California | 20802 |
1 |
| Abbvie Inc. | 1822 |
1 |
| Takeda Pharmaceutical Company Limited | 2712 |
1 |
| Aphp (assistance Publique-hopitaux de Paris) | 70 |
1 |
| Arena Pharmaceuticals, Inc. | 345 |
1 |
| Astellas Pharma Inc. | 1039 |
1 |
| Daiichi Sankyo Company, Limited | 1891 |
1 |
| Ecole Pratique des Hautes Etudes | 40 |
1 |
| ICM - Institut du Cerveau et de La Moelle Epiniere | 65 |
1 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3333 |
1 |
| Other owners | 10 |